Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


Resources

A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Updates

Featured resources and latest news from the Exchanges blog

blog

Global Standards for Reporting Clinical Trial Results Gets Boost
Several of the world’s major medical research funders and developers have agreed on new standards requiring that their clinical trials be publicly registered and all results disclosed.
blog

Multi-purpose Vaginal Ring Phase I Trial Initiated
A Phase I randomized clinical trial of a multi-purpose vaginal ring to prevent HIV and unintended pregnancy has begun. It is the first study in humans of a ring containing both an antiretro...
resource

Calliope, the Contraceptive Pipeline Database
Calliope, the Contraceptive Pipeline Database, provides information on new and future contraceptive products, including long-acting and novel products currently only available in li...
blog

Sayana® Press Price Reduction Announced
The injectable contraceptive, Sayana® Press, will now be available to qualified purchasers at a guaranteed public sector price of US $0.85 per dose for the next six years. The longer-acting...
blog

ICFP heads to Kilgali, Rwanda in 2018
The Bill and Melinda Gates Foundation and the Rwandan Ministry of Health will co-host the fifth International Conference on Family Planning, set to take place in Kigali in November, 2018.
blog

Dynamic 3-D Female Tract Model Developed
Scientists at Northwestern University, the University of Illinois at Chicago and Draper Laboratory have developed EVATAR, a microenvironment that mimics how organs in the female reproductive...
blog

A Call for Concepts: On-demand Contraceptives
The Bill & Melinda Gates Foundation has announced an invitation for concept memos to explore the feasibility of developing a novel on-demand contraceptive for women.
blog

WHO revises guidance on injectable contraceptive use among women ...
The World Health Organization (WHO) continues to monitor the scientific evidence around the topic of whether hormonal contraceptive use increases a woman’s risk of acquiring HIV. A specia...
blog

Efficacy of Dot Fertility Window App to be Tested
Researchers have launched a year-long study to measure the efficacy of Dot™, a smart phone app that uses an algorithm to accurately predict a woman’s pregnancy risk for each day of her c...
event

Webinar on WHO PQ Collaborative Procedure for Accelerated Registr...
Upcoming RHSC webinar will outline the steps in WHO's collaborative procedure to expedite national registration of prequalified healthcare products and avoid obstacles to country-level commo...
blog

Male Contraception Initiative Issues Call for Proposals
The Male Contraception Initiative is offering up to $500,000 in funding over three years to one or more recipients for research to advance the development of a new, reversible male contracep...
blog

Mithra seeks FDA Approval of its New Vaginal Ring
Mithra Pharmaceuticals announced on January 24, 2017 its intention to submit Myring, a combined hormonal contraceptive vaginal ring, for marketing approval in both Europe and the United Stat...

Contribute

We want you to join the exchange!

Contribute

The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback